×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
PABPN1 Antikörper (C-Term)
PABPN1
Reaktivität: Human
WB, EIA
Wirt: Kaninchen
Polyclonal
unconjugated
Produktdetails anti-PABPN1 Antikörper
(ausblenden)
Target
Alle PABPN1 Antikörper anzeigen
PABPN1
(Poly A Binding Protein Nuclear 1 (PABPN1))
Bindungsspezifität
Alle Epitope für PABPN1 Antikörper
AA 269-298, C-Term
Reaktivität
Alle Reaktivitäten für PABPN1 Antikörper
Human
Wirt
Alle Wirte für PABPN1 Antikörper
Kaninchen
Klonalität
Alle Klonalitäten für PABPN1 Antikörper
Polyklonal
Konjugat
Alle Konjugate für PABPN1 Antikörper
Dieser PABPN1 Antikörper ist unkonjugiert
Applikation
Alle Applikationen für PABPN1 Antikörper
Western Blotting (WB), Enzyme Immunoassay (EIA)
Spezifität
This antibody recognizes Human PABPN1 (C-term).
Aufreinigung
Protein A column, followed by peptide affinity purification
Immunogen
KLH conjugated synthetic peptide between 269-298 amino acids from the C-terminal region of human PABPN1
Isotyp
Ig Fraction
Top Product
Discover our top product PABPN1 Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Liquid
Konzentration
0.25 mg/mL
Buffer
PBS containing 0.09 % (W/V) Sodium Azide as preservative
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Details zu PABPN1
(ausblenden)
Target
PABPN1
(Poly A Binding Protein Nuclear 1 (PABPN1))
Andere Bezeichnung
PABPN1 (PABPN1 Produkte )
Synonyme
OPMD antikoerper, PAB2 antikoerper, PABII antikoerper, PABP-2 antikoerper, PABP2 antikoerper, Pabp3 antikoerper, mPABII antikoerper, ARABIDOPSIS POLY(A) BINDING 2 antikoerper, ATPAB2 antikoerper, F28A23.130 antikoerper, F28A23_130 antikoerper, POLY(A) BINDING PROTEIN 2 antikoerper, POLY(A)-BINDING PROTEIN 2 antikoerper, poly(A) binding protein 2 antikoerper, opmd antikoerper, pab2 antikoerper, pabp2 antikoerper, pabpii antikoerper, pabpn1 antikoerper, Pabpn1 antikoerper, Poly(A)-binding protein 2 antikoerper, fb19c03 antikoerper, wu:fb17e03 antikoerper, wu:fb18c06 antikoerper, wu:fb19c03 antikoerper, zgc:85979 antikoerper, zgc:92452 antikoerper, poly(A) binding protein nuclear 1 antikoerper, poly(A) binding protein, nuclear 1 antikoerper, poly(A) binding protein 2 antikoerper, poly(A) binding protein, nuclear 1 S homeolog antikoerper, poly(A) binding protein, nuclear 1 L homeolog antikoerper, polyadenylate-binding protein 2 antikoerper, poly(A) binding protein Pab2 antikoerper, PABPN1 antikoerper, Pabpn1 antikoerper, PAB2 antikoerper, pabpn1.S antikoerper, pabpn1.L antikoerper, LOC100728725 antikoerper, pab2 antikoerper, pabpn1 antikoerper
Hintergrund
This gene encodes an abundant nuclear protein that binds with high affinity to nascent poly(A) tails. The protein is required for progressive and efficient polymerization of poly(A) tails on the 3' ends of eukaryotic genes and controls the size of the poly(A) tail to about 250 nt. At steady-state, this protein is localized in the nucleus whereas a different poly(A) binding protein is localized in the cytoplasm. An expansion of the trinucleotide (GCG) repeat from normal 6 to 8-13 at the 5' end of the coding region of this gene leads to autosomal dominant oculopharyngeal muscular dystrophy (OPMD) disease. Multiple splice variants have been described but their full-length nature is not known. One splice variant includes introns 1 and 6 but no protein is formed.Synonyms: Nuclear poly(A)-binding protein 1, PAB2, PABP-2, PABP2, Poly(A)-binding protein 2, Polyadenylate-binding nuclear protein 1, Polyadenylate-binding protein 2
Molekulargewicht
32749 Da
Gen-ID
8106
NCBI Accession
NP_004634
Zuletzt angesehen
(ausblenden)